Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Exelixis: Up 32% With Room to Run
Exelixis: Up 32% With Room to Run
Exelixis: Up 32% With Room to Run
Submitted by
admin
on November 20, 2010 - 12:08pm
Source:
Motley Fool
News Tags:
XL184
ovarian cancer
prostate cancer
Exelixis
Bristol-Myers Squibb
Headline:
Exelixis: Up 32% With Room to Run
Do Not Allow Advertisers to Use My Personal information
